- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Shanghai Reunion Biotech Co.,Ltd.
Total 1814 results
-
Cutia Therapeutics (Shanghai) Co., LtdCompleted
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingAdvanced Hepatocellular Carcinoma (HCC)Italy, Poland, Singapore, United States, China, Ukraine
-
Nuance Pharma (shanghai) Co., LtdCompletedChronic Obstructive Pulmonary DiseaseChina
-
Shanghai Zerun Biotechnology Co.,LtdCompletedHuman PapillomavirusChina
-
Shanghai Junshi Bioscience Co., Ltd.WithdrawnPrimary Condition: Advanced TumorsChina
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingHepatocellular CarcinomaChina
-
Nuance Pharma (shanghai) Co., LtdCompleted
-
Shanghai Pharmaceuticals Holding Co., LtdCompletedChronic Abnormal Immune Activation in HIV/AIDSChina
-
Shanghai Hengrui Pharmaceutical Co., Ltd.CompletedPostsurgical Pain ManagementChina
-
Mabwell (Shanghai) Bioscience Co., Ltd.Completed
-
Shanghai Vinnerna Biosciences Co., Ltd.Withdrawn
-
Shanghai Kanda Biotechnology Co., Ltd.Completed
-
Shanghai Junshi Bioscience Co., Ltd.CompletedTreatment-naive Advanced Non-small Cell Lung CancerChina
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingRecurrent or Metastatic NPCChina, Taiwan, Singapore
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruiting
-
Shanghai Pharmaceuticals Holding Co., LtdCompletedCD20 Positive B Cell Non-Hodgkin's LymphomaChina
-
Shanghai Pharmaceuticals Holding Co., LtdWithdrawn
-
Shanghai Biomabs Pharmaceutical Co., Ltd.Completed
-
Shanghai Yizhong Biotechnology Co., Ltd.UnknownNon-Small Cell Lung Cancer(NSCLC)China
-
Mabwell (Shanghai) Bioscience Co., Ltd.Completed
-
Mabwell (Shanghai) Bioscience Co., Ltd.UnknownAdvanced Solid TumorChina
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
Shanghai Junshi Bioscience Co., Ltd.UnknownSmall Cell Lung CancerChina
-
Shanghai YingLi Pharmaceutical Co. Ltd.UnknownDiffuse Large B Cell Lymphoma
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
Shanghai Junshi Bioscience Co., Ltd.UnknownCOVID-19; and High Infection Risk of SARS-CoV-2China
-
Shanghai YingLi Pharmaceutical Co. Ltd.UnknownLymphoma, FollicularChina
-
Shanghai Junshi Bioscience Co., Ltd.CompletedHypercholesterolemiaChina
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
Shanghai Junshi Bioscience Co., Ltd.Unknown
-
Shanghai YingLi Pharmaceutical Co. Ltd.UnknownB-cell Chronic Lymphocytic Leukemia | B-cell Lymphoma RecurrentChina
-
Shanghai Greenvalley Pharmaceutical Co., Ltd.CompletedCognitive Impairment | Mild to Moderate Alzheimer DiseaseChina
-
Shanghai Greenvalley Pharmaceutical Co., Ltd.CompletedStable Angina PectorisChina
-
Shanghai Greenvalley Pharmaceutical Co., Ltd.Completed
-
Shanghai Acebright Pharmaceuticals Co., Ltd.UnknownMalignant Advanced Solid TumorChina
-
Shanghai Pharmaceuticals Holding Co., LtdCompletedAnkylosing SpondylitisChina
-
Shanghai Shyndec Pharmaceutical Co., Ltd.Unknown
-
Shanghai Escugen Biotechnology Co., LtdNot yet recruitingMetastatic Breast CancerChina
-
Shanghai Ark Biopharmaceutical Co., Ltd.Not yet recruiting
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingCldn18.2-positive Advanced Solid TumorChina
-
Shanghai Shengdi Pharmaceutical Co., LtdNot yet recruitingNon-squamous Non-small Cell Lung CancerChina
-
Genrix (Shanghai) Biopharmaceutical Co., Ltd.Not yet recruitingRespiratory Syncytial Virus InfectionsChina
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingSecondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on HemodialysisChina
-
Shanghai Huaota Biopharmaceutical Co., Ltd.RecruitingGeneralized Pustular Psoriasis (GPP)China
-
Shanghai Huaota Biopharmaceutical Co., Ltd.RecruitingCervical Cancer | Advanced Solid TumorChina
-
Genrix (Shanghai) Biopharmaceutical Co., Ltd.Not yet recruiting
-
Mabwell (Shanghai) Bioscience Co., Ltd.RecruitingModerate to Severe Chronic Obstructive Pulmonary Disease (COPD)China
-
Shanghai Junshi Bioscience Co., Ltd.Recruiting
-
Shanghai Vinnerna Biosciences Co., Ltd.Recruiting
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingHigh-risk Non-muscle Invasive Bladder CancerChina